Solid Biosciences Stock (NASDAQ: SLDB) stock price, news, charts, stock research, profile.
You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.
Other companies in Solid Biosciences’s space includes: Humacyte (NASDAQ:HUMA), Celcuity (NASDAQ:CELC), Upstream Bio (NASDAQ:UPB), Altimmune (NASDAQ:ALT) and Sage Therapeutics (NASDAQ:SAGE).
Solid Biosciences has a consensus price target of $15.60.
The stock price for Solid Biosciences (NASDAQ: SLDB) is $6.1188 last updated February 21, 2025 at 7:59 PM EST.
There are no upcoming dividends for Solid Biosciences.
Solid Biosciences’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Solid Biosciences.
Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.